- Home
- ARTL vs GORV Comparison
ARTL vs GORV Comparison
Compare ARTL & GORV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARTL
- GORV
- Stock Information
- Founded
- ARTL 2011
- GORV 1976
- Country
- ARTL United States
- GORV United States
- Employees
- ARTL 6
- GORV N/A
- Industry
- ARTL Biotechnology: Pharmaceutical Preparations
- GORV Retail-Auto Dealers and Gas Stations
- Sector
- ARTL Health Care
- GORV Consumer Discretionary
- Exchange
- ARTL Nasdaq
- GORV Nasdaq
- Market Cap
- ARTL 8.4M
- GORV 9.3M
- IPO Year
- ARTL N/A
- GORV 2015
- Fundamental
- Price
- ARTL $3.97
- GORV $2.25
- Analyst Decision
- ARTL Buy
- GORV
- Analyst Count
- ARTL 2
- GORV 0
- Target Price
- ARTL $30.00
- GORV N/A
- AVG Volume (30 Days)
- ARTL 69.0K
- GORV 1.7M
- Earning Date
- ARTL 11-11-2025
- GORV 11-17-2025
- Dividend Yield
- ARTL N/A
- GORV N/A
- EPS Growth
- ARTL N/A
- GORV N/A
- EPS
- ARTL N/A
- GORV N/A
- Revenue
- ARTL N/A
- GORV $662,952,000.00
- Revenue This Year
- ARTL N/A
- GORV $15.65
- Revenue Next Year
- ARTL N/A
- GORV $20.54
- P/E Ratio
- ARTL N/A
- GORV N/A
- Revenue Growth
- ARTL N/A
- GORV N/A
- 52 Week Low
- ARTL $3.91
- GORV $1.83
- 52 Week High
- ARTL $28.60
- GORV $58.80
- Technical
- Relative Strength Index (RSI)
- ARTL 32.84
- GORV 44.69
- Support Level
- ARTL $3.94
- GORV $1.96
- Resistance Level
- ARTL $4.54
- GORV $2.35
- Average True Range (ATR)
- ARTL 0.35
- GORV 0.34
- MACD
- ARTL 0.06
- GORV 0.02
- Stochastic Oscillator
- ARTL 2.91
- GORV 32.06
About ARTL Artelo Biosciences Inc.
Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.
About GORV Lazydays Holdings Inc.
Lazydays Holdings Inc operates recreational vehicle dealerships. It provides products and services for RV owners and outdoor enthusiasts. The company generates revenue by providing a full spectrum of RV products: New and pre-owned RV sales, RV parts and services, financing and insurance products, third-party protection plans, after-market parts and accessories, and RV camping facilities.